Chargement en cours...
Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
The purpose of this study was to compare the efficacy of intravitreal aflibercept versus ranibizumab for treating therapy-resistant diabetic macular oedema (DME). A 69-year-old man presented with persistent bilateral DME despite previous ranibizumab treatment. Bilateral study treatment comprised one...
Enregistré dans:
| Publié dans: | Int Ophthalmol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Netherlands
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4488481/ https://ncbi.nlm.nih.gov/pubmed/25989873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10792-015-0081-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|